Oral Oncology
Volume 38, Issue 6 , Pages 543-548, September 2002

Growth of human squamous cell carcinoma xenografts in mice is inhibited by local angiostatin gene therapy

  • G Matsumoto

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, Kanagawa Dental College, 82 Inaoka, Yokosuka, Kanagawa, 238-8580 Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-468-22-8895; fax: +81-468-22-8801
  • ,
  • K Sasakuri

      Affiliations

    • Department of Orthodontics, Kanagawa Dental College, 82 Inaoka, Yokosuka, Kanagawa, 238-8580 Japan
  • ,
  • K Tsukinoki

      Affiliations

    • Department of Oral Pathology, Kanagawa Dental College, 82 Inaoka, Yokosuka, Kanagawa, 238-8580 Japan
  • ,
  • Y Ohmi

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, Kanagawa Dental College, 82 Inaoka, Yokosuka, Kanagawa, 238-8580 Japan
  • ,
  • U Lee

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, Kanagawa Dental College, 82 Inaoka, Yokosuka, Kanagawa, 238-8580 Japan
  • ,
  • J Shindo

      Affiliations

    • First Department of Oral and Maxillofacial Surgery, Kanagawa Dental College, 82 Inaoka, Yokosuka, Kanagawa, 238-8580 Japan

Received 18 October 2001; accepted 4 November 2001.

Abstract 

The possibility of inhibiting tumor growth by blocking the formation of new tumor vessels has recently received attention. Antiangiogenic tumor therapies have recently attracted intense interest because of their direct endothelial targeting and the absence of drug resistance. Local antiangiogenic gene therapy for cancer offers a potential way to achieve sustained therapeutic release of antiangiogenic substances. As a step toward this goal, we used liposomes complexed to angiostatin cDNA and targeted to human squamous cell carcinoma cell lines in vivo. Tumor cells expressing angiostatin after local gene transfer showed markedly reduced vascularity and contained many apoptotic tumor cells. These results demonstrate the potential utility of liposome-derived angiostatin for adjuvant therapy of oral cancer in humans.

Keywords:  Angiostatin, Gene therapy, Squamous cell carcinoma

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(01)00126-9

Oral Oncology
Volume 38, Issue 6 , Pages 543-548, September 2002